Literature DB >> 31535767

Hidradenitis suppurativa in a prepubertal case series: a call for specific guidelines.

A Offidani1, E Molinelli1, A Sechi2, V Brisigotti1, A Campanati1, B Raone2, I Neri2, A Patrizi2.   

Abstract

Hidradenitis suppurativa (HS) is a chronic, recurrent, inflammatory disease associated with a high physical and psychological burden. It is a disorder of the infundibular segment of the pilosebaceous unit, characterized by subcutaneous nodules, abscesses, sinus tracts and scar formation on the intertriginous and apocrine-bearing areas. HS is quite rare in young and prepubertal children. It usually begins after puberty, but several reports of prepubertal HS onset have been described. These cases are strongly linked to hormonal disorders and genetic susceptibility. Specific guidelines for prepubertal patients are still lacking, so further studies are warranted to better delineate a tailored approach. This paper aims to summarize the most significant aspects, as well as the most recent information about the epidemiology, pathogenesis, clinical features, diagnosis, comorbidities and treatment of paediatric HS. In addition, we report our clinical experience in managing HS in a group of eight prepubertal patients based on systemic antibiotics (azithromycin) and zinc oral supplementation.
© 2019 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31535767     DOI: 10.1111/jdv.15827

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  2 in total

1.  Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate-to-severe hidradenitis suppurativa.

Authors:  Elisa Molinelli; Claudia Sapigni; Oriana Simonetti; Giulia Radi; Daisy Gambini; Andrea Maurizi; Giulio Rizzetto; Giovanni Marco D'Agostino; Annamaria Offidani
Journal:  Dermatol Ther       Date:  2022-06-28       Impact factor: 3.858

2.  Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild-to-moderate hidradenitis suppurativa: A retrospective study.

Authors:  Elisa Molinelli; Valerio Brisigotti; Oriana Simonetti; Claudia Sapigni; Giovanni Marco D'Agostino; Giulio Rizzetto; Alfredo Giacchetti; Annamaria Offidani
Journal:  Dermatol Ther       Date:  2022-03-18       Impact factor: 3.858

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.